You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 28, 2025

Drug Price Trends for NDC 00574-0792


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 00574-0792

Drug NameNDCPrice/Unit ($)UnitDate
PILOCARPINE HCL 5 MG TABLET 00574-0792-01 0.35037 EACH 2025-04-23
PILOCARPINE HCL 5 MG TABLET 00574-0792-01 0.35110 EACH 2025-03-19
PILOCARPINE HCL 5 MG TABLET 00574-0792-01 0.31457 EACH 2025-02-19
PILOCARPINE HCL 5 MG TABLET 00574-0792-01 0.26994 EACH 2025-01-22
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 4 of 4 entries

Best Wholesale Price for NDC 00574-0792

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Market Analysis and Price Projections for Drug NDC: 00574-0792

Understanding the National Drug Code (NDC)

To begin analyzing the market and price projections for a specific drug identified by its National Drug Code (NDC), it is crucial to understand what the NDC represents. The NDC is a unique, three-segment number that serves as a universal product identifier for drug products in the United States. This code is used to identify prescription drugs, over-the-counter (OTC) drugs, and insulin products that are manufactured, prepared, propagated, compounded, or processed for commercial distribution[5].

Identifying the Drug

The NDC 00574-0792 corresponds to a specific drug product. To identify this drug, one would need to refer to the FDA's National Drug Code Directory, which contains detailed information about finished and unfinished drugs, including their active ingredients, dosage forms, and marketing status[1].

Market Analysis

Current Market Status

  • The FDA's NDC Directory provides insights into whether the drug is currently in commercial distribution, its marketing start and end dates, and any changes in its listing status. For instance, if the drug has a future marketing end date, it indicates that the product will be delisted but remains active until that date[1].

Pricing Trends

  • Prescription drug prices, including those for the drug in question, are often subject to significant fluctuations. Annual price increases can range from 10% to 20%, attributed to factors such as rebates, co-pay assistance programs, research and development costs, and shareholder obligations[2].

Global Price Comparisons

  • U.S. prices for prescription drugs are typically higher than those in other countries. For example, cardiovascular drugs in the U.S. can have median prices around $580, while in other countries, the prices range from $5 to $164. This disparity highlights the complex pricing dynamics in the pharmaceutical market[2].

Pharmaceutical Supply Chain

  • The price of a prescription drug is influenced by various entities within the pharmaceutical supply chain, including manufacturers, wholesale distributors, and health insurers. Transparency across these entities is crucial for understanding the factors contributing to the final price of the drug[2].

Price Projections

Advanced Projections Models

  • Companies like Komodo Health use advanced statistical methods and real-time data to provide accurate drug projections. These models calculate probability estimates of coverage for individual drugs and incorporate new data to adjust for trend breaks and other disruptions. This approach helps in predicting market share and identifying competitive opportunities[4].

Key Insights

  • To project the price of the drug NDC 00574-0792, one would need to analyze historical pricing data, market trends, and the competitive landscape. This includes tracking the drug's payer and provider mix over time and adjusting projections based on observed events and projected data[4].

Impact of Regulatory Changes

  • Regulatory and policy changes can significantly impact drug pricing. For instance, changes in health policies, tariffs, and taxes can accelerate changes in the pharmaceutical market. Companies must stay abreast of these changes to accurately project future prices and market dynamics[3].

Industry Trends and Their Impact

Focus on Prevention and Personalization

  • The pharmaceutical industry is shifting towards prevention, personalization, and prediction. This includes using data-driven, customized treatments based on genetics and behavior. Such trends can influence the demand and pricing of specific drugs as the market moves towards more targeted therapies[3].

Role of Emerging Technologies

  • The use of AI and other emerging technologies is revolutionizing the drug development process. Companies that invest in these technologies can reduce development timelines and costs, potentially affecting the pricing and market share of existing drugs[3].

Case Study: High-Cost Drugs

Example of High-Cost Biologics

  • Drugs like Humira, which are biologics, often have high prices and significant market impact. For example, in Oregon, Humira cost health insurers approximately $220 million to fill claims for about 6,000 patients in 2018. Such high-cost drugs are subject to intense scrutiny and regulatory oversight, which can influence their pricing and market projections[2].

Visualizing Projected Insights

Using Data Dashboards

  • Tools like Komodo Health's dashboard allow analysts to compare total observed vs. projected values for a holistic view of the market. This includes using confidence intervals to inform scenario models and sensitivity analyses, enabling more accurate price projections[4].

Key Takeaways

  • NDC Directory: The FDA's NDC Directory is a critical resource for identifying and tracking drug products.
  • Pricing Trends: Drug prices are influenced by multiple factors, including rebates, R&D costs, and supply chain dynamics.
  • Advanced Projections: Using real-time data and advanced statistical methods can improve the accuracy of drug price projections.
  • Regulatory Impact: Changes in health policies and regulatory environments can significantly affect drug pricing and market dynamics.
  • Industry Trends: Shifts towards prevention, personalization, and the use of emerging technologies are transforming the pharmaceutical market.

FAQs

Q: What is the National Drug Code (NDC) and how is it used?

  • The NDC is a unique three-segment number used to identify prescription drugs, OTC drugs, and insulin products in the United States. It serves as a universal product identifier for these drug products.

Q: Why do U.S. prescription drug prices tend to be higher than those in other countries?

  • U.S. prices are often higher due to factors such as rebates, co-pay assistance programs, research and development costs, and shareholder obligations.

Q: How do companies like Komodo Health project drug prices?

  • Komodo Health uses advanced statistical methods, real-time data, and multiple views of the U.S. healthcare system to provide accurate drug projections.

Q: What impact do regulatory changes have on drug pricing?

  • Regulatory changes, including health policies, tariffs, and taxes, can significantly influence drug pricing and market dynamics.

Q: How are emerging technologies changing the pharmaceutical industry?

  • Emerging technologies like AI are revolutionizing the drug development process, reducing timelines and costs, and potentially affecting the pricing and market share of existing drugs.

Sources

  1. FDA's National Drug Code Directory - FDA
  2. Prescription Drug Price Transparency Results and Recommendations - Oregon Drug Price Transparency Program
  3. Pharma industry trends: PwC
  4. Drug Projections | Komodo Health
  5. National Drug Code Database Background Information - FDA

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.